Nihon Chouzai Co Ltd
TSE:3341
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
JP |
Nihon Chouzai Co Ltd
TSE:3341
|
42B JPY | 8.1 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
75.2B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.9B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.8B USD | 12 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
46.4B BRL | 23.7 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
46B CNY | 23.5 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
912.1B JPY | 11.5 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.9B SAR | 18.6 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
78.3B MXN | 8.8 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
555.4B JPY | 17.5 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.8B CNY | 19 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.